Navigation Links
Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources
Date:10/13/2009

Research, said "We are very proud to have reached this key milestone in advance on schedule. We have benefited from the assistance of Genoscope and of the analytical chemistry platform of Evry-Val d'Essonne University. The bioproduction of a gaseous hydrocarbon will make it possible to obtain pure products at high yield and low cost.".

According to Prof. Dieter Soll, "The data on isobutene formation presented by Global Bioenergies are convincing, and I am now impatient to see the process optimized and scaled up."

"Development of such an artificial metabolic pathway represents a signal accomplishment with enormous implications. Standard technologies for enzyme and metabolic engineering can now be applied to transform this proof of concept into a viable industrial process," added Prof. Donald Hilvert.

Marc Delcourt, cofounder and CEO of the company concludes: "We are now focusing on industrializing the process, which will be financed through a second round currently in preparation."

Please visit our new web site: http://www.global-bioenergies.com

SOURCE Global Bioenergies


'/>"/>
SOURCE Global Bioenergies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care
2. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
3. Biotechnology Can Address Global Mega Trends, DuPont Leader Says
4. Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering
5. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
6. Global Biofuels Growth to Double by 2015
7. DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
8. Global Public Health the Focus of Scientific Conference
9. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
10. Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
11. Fortebio, Inc. to Present at UBS Global Life Sciences Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009).../PRNewswire/--HealthRoboticstodayannounced,thatith...ed,investors.ThisrecentlyformedToronto-basedcompan...andwillmarket,install,andsupport,HealthRobotics,i....onaryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),...eassistanceonan"asneeded,basis"toitsstrategicpartn...
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...ltra-fast communication, computation and more powe...ying to use quantum states as carriers of informat...sicists have shown, mathematically, how to gently ... while keeping the information intact. Their work ...ew Letters and highlighted with a Viewpoint in P...
(Date:11/23/2009)...PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: ...ythatidentifiesandadvancesadiverseportfolioofpromi...ment,todayreportedthatCytopia(ASX:CYT)hascommenced...t,orally-administeredJAK1/JAK2inhibitor.Thetrialis...roposaltomergeCytopiaintoYMhasbeenpreviouslyannoun...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
... The cell proliferation assay is an important...ion and in the search for new drugs. Productivity ...f automated, high throughput sample processing and...he TopCount Microplate Scintillation Counter help ...iferation assay are presented which compare the pe...
...resolved fluorescence assay for inhibition of poly...late assay that measures the inhibition of PARP-ac... adenine diphsophate (NAD). The incorporation is d...ethod is a convenient way to screen test compounds...ening and secondary screening. , Poly(ADP-...
...roduction , A phosphorimeter integral to... SPEX FLUOROLOG system can uncover important i...hemical interest, by revealing data normally maske...,>This Application Note describes an example, usin...om a peptide-terbium-complex donor to a fluorescei...
Other Biology Technology:Cell Proliferation Assays 2Cell Proliferation Assays 3A DELFIA Assay for Inhibition of PARP 2A DELFIA Assay for Inhibition of PARP 3Phosphorescence lifetime measured using the SPEX phosphorimeter 2
(Date:11/25/2009)... On September 11, firefighters, police officers a...ort in the World Trade Center complex. They battle...searched for survivors, tackled fires and evacuate...ntained an estimated 17,000 people. And making the...ications: frightened workers and their relatives j...
(Date:11/25/2009)... Over the course of a lifetime, the heart pumps s...In the order to do this, the muscle fibers of the ...roup headed by Dr. Wolfgang Rottbauer, vice chair ...iversity Hospital (Chairman: Prof. Dr. H. A. Katus...r the stability of the smallest muscular unit, the...
(Date:11/24/2009)... For thousands of years it has been prescribed by... ailments from headaches and stomach pain to fever...t Newcastle University have been able to scientifi...is crenata otherwise known as Brazilian mint. ,... the team led by researcher Graciela Rocha was abl...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2Cystic Fibrosis Treatment May Cause Hearing Loss 50673 1Prostate cancer patients disease free after five years likely to be disease free after 10 years 50669 1Emdeon Acquires eRx Network LLC 50665 1Emdeon Acquires eRx Network LLC 50665 2Emdeon Acquires eRx Network LLC 50665 3
... soon for the 61st Annual Meeting of the Rocky Mou..., being held 11-13 May 2009 in Orem, Utah. Utah V...heir new library building on the UVU campus. Brigh...l program, presented by academic and industry scie...ill highlight cutting-edge scientific research in ...
...ers at the University of Illinois have developed a...delivery of one or more molecules into the cytopla...ferrying tiny amounts of cargo, the nanoneedle can...n optical biosensor., "Nanoneedle-based delivery ...cesses and biophysical properties at the molecular...
...athletic trainers associated with National Collegi... they were following best practice standards for m...a new study. , For athletes with asthma, the dang...thletic performance or so severe to be incapacitat...e American College of Sports Medicine,s journal, ...
Other Biology News:Geoscientists meet to discuss Rocky Mountain geology 2Nanoneedle is small in size, but huge in applications 2Athletes with asthma need more help from their team trainers 2
Cassette, Sal I from Takara Mirus Bio
pZeoSV2(+) Vector Kit from Invitrogen
Rabbit anti-QKI AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Acrylamide from GE Healthcare, formerly Amersham Biosciences
Biology Products: